Corporate organisations are willing to make a substantial upfront investment for innovative IT/telephony, including ongoing licensing, for those products that deliver efficiencies to their bottom line. What they are not willing to accept is a product that functions like Windows 10.
NOR's extensive testing of CORONA gives such organisations the belief and confidence that this is a product that has had the bugs worked out. Rather than being the test dummy corp for the product.
Apple could have released a pencil (stylus) years ago when it brought out the iPad, however they chose to wait until they had it perfect.
The "wait" will be worth it, because I'd rather invest in a company that signs long term large contracts because they have a product that works. Than a company who won a few contracts to then announce their product doesn't exactly do what it had set out to achieve.
- Forums
- ASX - By Stock
- NOR
- Ann: Company Update and Quarterly Reporting-NOR.AX
Ann: Company Update and Quarterly Reporting-NOR.AX, page-32
Featured News
Add NOR (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.24M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 64999 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.8¢ | 26342 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 64999 | 0.032 |
1 | 100000 | 0.031 |
1 | 13400 | 0.030 |
1 | 96000 | 0.028 |
1 | 180000 | 0.027 |
Price($) | Vol. | No. |
---|---|---|
0.038 | 26342 | 1 |
0.039 | 126001 | 1 |
0.040 | 123849 | 1 |
0.042 | 23833 | 1 |
0.044 | 44101 | 2 |
Last trade - 16.12pm 12/11/2024 (20 minute delay) ? |
Featured News
NOR (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online